MedPath

Vestibular Balance Therapy Intervention for Children

Not Applicable
Recruiting
Conditions
Vestibular Disorder
Bilateral Vestibular Loss
Vestibulocochlear Nerve Diseases
Registration Number
NCT05741515
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

The goal of this within groups clinical trial is to determine the feasibility of a home-based vestibular balance therapy program for children with vestibular hypofunction. The main questions to be answered are: 1) what is the intervention's feasibility and 2) what is the intervention's preliminary impact on function? Participants will receive a comprehensive battery of vestibular function and balance tests, then an 8-week home-based intervention to be done 5 times/week with weekly checks from the physical therapist. Data will be used to design a larger clinical trial with a comparison group.

Detailed Description

Approximately 60-75% of children with severe/profound sensorineural hearing loss (SNHL) also have vestibular hypofunction (VH), resulting in delayed gross motor development, poor postural control, and gaze instability. Although clinical practice guidelines provide recommendations for adults with VH, no statements exist for children due to a paucity of high- level studies. The long-term objective of this proposal is to assess feasibility of a home-based vestibular balance therapy (VBT) program for children so that a larger well-powered controlled study can be designed. The specific aims are to assess the intervention's feasibility (Aim 1), estimate its preliminary impact on functional outcomes (Aim 2), and assess participant engagement (secondary Aim). To accomplish this, we will use a prospective single arm feasibility design. We will enroll 15 children with SNHL, aged 4-17 years; 12 with confirmed VH for the VBT, and 3 with normal vestibular function to test the sham intervention. All children will be tested on the functional outcomes: computerized dynamic visual acuity, modified functional gait assessment, and sensory organization test at baseline, 4, and 8 weeks. A physical therapist (PT) will train children/caregivers in the 8-week structured VBT home program consisting of 4 categories of exercises (Times 1 viewing, gaze shifting, static and dynamic balance) done 5 times/week, 5 minutes/exercise. The PT will meet weekly with the child/caregiver in person to systematically progress the exercises. The children in the sham intervention (10 minutes of reading, 10 minutes of play) will also receive weekly meetings with the PT to control for attention bias. To assess Aim 1 (Feasibility) metrics will include process (e.g., recruitment rates), resources (e.g., communication needs), management (e.g., data collection/entry), experience (e.g., barriers). To assess Aim 2 (impact) we will analyze within group changes and effect sizes to design the larger study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • confirmed diagnosis of severe to profound SNHL
  • age 4-17 years
  • caregiver/child verbal willingness to commit to the home vestibular balance therapy or sham intervention
  • vision screening/testing within 1 year or willingness to get a vision test.
Exclusion Criteria
  • neurologic condition other than SNHL
  • inability to read at a kindergarten level or identify pictures
  • currently receiving vestibular therapy
  • uncorrected vision problems unrelated to a vestibular deficit

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Sensory Organization Test at 4 and 8 weeksBaseline (pre), 4 weeks (mid), 8 weeks (post)

A standardized test of static postural control

Change in Computerized Dynamic Visual Acuity at 4 and 8 weeksBaseline (pre), 4 weeks (mid), 8 weeks (post)

Difference in visual acuity with the head stationary versus moving

Change in Functional Gait Assessment at 4 and 8 weeksBaseline (pre), 4 weeks (mid), 8 weeks (post)

A standardized test of dynamic balance

Secondary Outcome Measures
NameTimeMethod
Process Feasibility (Retention Rates)through study period at 2 years

% of retention

Participant Experience Feasibility (Enjoyment)through the study period at 2 years

Enjoyment level for each participant (ordinal scale of 0=no enjoyment to 10=extreme enjoyment)

Management Feasibility (training)through year 1

time in minutes to train data collectors

Participant Experience Feasibility (Strategies)through study period at 2 years

participant strategies that helped them with participation in the study (interview)

Process Feasibility (Refusal Rate Frequency)through study completion at 2 years

Frequency of refusal to participate in the study

Process Feasibility (Completion Rates)through study period at 2 years

% of participants who complete 80% of intervention sessions

Resource Feasibility (frequency)through study period at 2 years

Frequency of communication with participants

Process Feasibility (Recruitment Rates)through study completion at 2 years

% of individuals who follow through with enrollment procedures

Process Feasibility (Attrition Rates)through study period at 2 years

% of attrition

Management Feasibility (data entry)through year 1

time in minutes for data entry

Participant Experience Feasibility (Testing Difficulty)baseline only - initial testing session

Participants will rate the level of difficulty of the initial testing session (0=not difficult to 10=extreme difficulty)

Participant Experience Feasibility (Intervention Difficulty)once, at each participant's final testing session (8 weeks)

Participants will rate the level of difficulty of the overall intervention (0=not difficult to 10=extreme difficulty)

Resource Feasibility (time)through study period at 2 years

Total time in minutes to communicate with participants

Trial Locations

Locations (1)

UAB

🇺🇸

Birmingham, Alabama, United States

UAB
🇺🇸Birmingham, Alabama, United States
Jennifer B Christy, PhD
Principal Investigator
Connie Bonds
Contact
205-934-5909
bondsc@uab.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.